Mesalamine Capsule, Extended Release
Product Images NDC 68382-452

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 68382-452). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3ef2b141 9ef9 4363 9c5b F70274e00d37 01)

Chemical structure diagram of mesalamine, showing a benzene ring with an amino group, hydroxyl group, and carboxylic acid group attached.*

FDA Label Image

Image (3ef2b141 9ef9 4363 9c5b F70274e00d37 02)

Mesalamine Extended-Release Capsules USP 0.375 g label from Zydus Pharmaceuticals USA Inc. The label includes the NDC 68382-452-19, indicates the package contains 120 capsules for oral use, and states the product is prescription only. Storage instructions note controlled room temperature conditions, child-resistant packaging, and warnings to keep out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.